These pages use javascript to create fly outs and drop down navigation elements.

Diabetes Empowerment Scale (DES)

Please note that this section is an archive (last updated in June 2006). [disclaimer]

Sections:   Overview | Instrument Reviews | Construct Overviews | Book Compendium Reviews | Internet Site Reviews

Created 2003 April 3
Jump To A Section

Practical Information | Research Contacts | Annotated Bibliography | Factors & Norms | Reliability Evidence | Validity Evidence | Comments | Updates | Feedback

Practical Information

Instrument Name:

Diabetes Empowerment Scale (DES)

Instrument Description:

In the early 1990’s, the Michigan Diabetes Research and Training Center (MDRTC) Education Committee concluded that the traditional medicine approach was inappropriate for application in diabetes patient education. They felt that the approach, based on the traditional view that the physician is in control of a patient’s care and that the patient must comply, did not take into account that diabetes patients are responsible for most of their care, most of the time. In answer to this dilemma, the MDRTC adopted the approach known as “patient empowerment.” Patient empowerment implies that a patient makes his or her own choices every day, which affect and are affected by the psychosocial aspects of living with a chronic disease. Under this approach, the purpose of diabetes patient education is to ensure that patients have the information needed to make informed choices. (Ref: 1,3)

The MDRTC has continued research into the area with a number of papers on patient empowerment. One such study was a randomized controlled trial designed to assess whether a patient empowerment education program was beneficial in increasing self-efficacy and reducing blood glucose levels. The authors were unable to find a measure of diabetes related self-efficacy for use in the study; therefore, they developed the Diabetes Empowerment Scale (DES) in order to assess the specific content areas of the empowerment program. (Ref: 1,3) The purpose of the DES is to measure psychosocial self-efficacy as an outcome of diabetes education interventions. (Ref: 3) This pilot version of the DES consisted of 37 items and 8 subscales. (Ref: 1-2) Most of the subscales were based on the behavior change model used in counseling psychology. (Ref: 3)

The authors determined that only three subscales on the pilot version of the DES had coefficient alphas >=0.80, therefore, they decided to reword the instrument in order to improve the psychometric properties. In revision, they reworded each item so that they were diabetes-specific. This resulted in a 28-item DES with 3 subscales: Managing the Psychosocial Aspects of Diabetes (9 items), Assessing Dissatisfaction and Readiness to Change (9 items), and Setting and Achieving Diabetes Goals (10 items). All items begin with the stem, “In general, I believe that I…” The authors reported that the DES may also be used to measure successful adaptation to and self-management of diabetes. (Ref: 3)

Price:

Free; available

Administration Time:

No information found.

Publication Year:

1995

Item Readability:

Flesch-Kincaid Grade Level=4.2, indicating that readers with at least a fourth grade education would be able to comprehend the instrument.

Scale Format:

5-point Likert scale (5=strongly agree, 1=strongly disagree)

Administration Technique:

Self-administered

Scoring and Interpretation:

An overall score is obtained by adding all item scores together and dividing by 28. Subscale scores may be obtained by adding all scores in that subscale together and dividing by the number of items in the subscale. Higher scores indicate higher levels of self-efficacy.

Forms:

A short form (the DES-SF) was published in 2003. (Ref 4)

Research Contacts

Instrument Developers:

Robert M. Anderson and the Michigan Diabetes Research and Training Center (MDRTC)

Instrument Development Location:

MDRTC
University of Michigan Medical School
Ann Arbor, Michigan

Instrument Developer Email:

boba@med.umich.edu

Instrument Developer Website:

www.med.umich.edu/mdrtc

Annotated Bibliography

1. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care. 1995 Jul;18(7):943-9. [PMID:7555554]
Purpose: To determine if patients participating in an empowerment program had improved psychosocial self-efficacy and attitudes toward Diabetes and a reduction in blood glucose levels.
Sample: Sixty-four patients, of which 70% were women and the mean age=50 years. 77% had some college, 64% with NIDDM, 54% using insulin, 84% had previous diabetes education.
Methods: The intervention group received one session of patient empowerment education per week, for six weeks, while the control group was assigned to a wait-list. After the initial 6 weeks, the control group began the 6 session program. Six weeks after the program ended, both groups were involved in follow-up.
Implications: Patient empowerment programs are effective interventions for addressing psychosocial self-efficacy and lead to improved blood glucose control. The intervention group showed post-intervention improvement on 4 of 8 subscales.

2. Via PS, Salyer J. Psychosocial self-efficacy and personal characteristics of veterans attending a diabetes education program. Diabetes Educ. 1999 Sep-Oct;25(5):727-37. [PMID: 10646469]
Purpose: To assess the influence of race, education and regimen differences in determining perceived self-efficacy, and compare these factors with perceived self-efficacy and attitudes toward diabetes.
Sample: 211 male patients attending a diabetes education program. Data was analyzed using 90 of these patients. Mean age=61 years, 47% Caucasian and 53% non-Caucasian, 48% with greater than high school education.
Methods: All patients completed the DES and Attitudes Toward Diabetes Scale (ATD) before the first class. At the first class, a baseline blood sample was taken and weight in pounds was recorded. Other measurements included the Diabetes Care Profile (DCP) and subscales of the Diabetes Attitude Scale (DAS).
Implications: Patients with less education were better able to obtain support and cope with feelings. Baseline glucose levels did not correlate with any measures of self-efficacy. Patient’s self-reported understanding of diabetes correlated with the DES and ATD.

3. Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care. 2000 Jun;23(6):739-43. [PMID:10840988]
Purpose: To assess validity, reliability and utility of the DES.
Sample: 375 patients involved in MDRTC outreach programs. Mean age=50.4 years, 55% women, 57% Type II Diabetes using insulin, 66% received diabetes education in the past, 73% completed some college.
Methods: The DES was mailed or administered to patients.
Implications: Evidence for the validity and reliability of a 28-item DES with 3 subscales was shown.

4. Anderson RM, Fitzgerald JT, Gruppen LD, Funnell MM, Oh MS. The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care. 2003 May;26(5):1641-1642. [PMID:12716841]
Purpose: To assess validity, reliability and utility of the DES-SF.
Sample: 229 patients involved in a 6-week problem-based patient education program.
Methods: The DES was administered to patients prior to and after the education program.
Implications: Evidence for the content validity and reliability of the 8-item DES was reported.

top

Factors and Norms

Factor Analysis Work:

Principal components analysis with varimax rotation was used to identify subscales. An iterative process was used to find the smallest number of meaningful factors, which resulted in a 3-factor solution which accounted for 56% of the total variance: Managing the Psychosocial Aspects of Diabetes (Eigenvalue=16.6), Assessing Dissatisfaction and Readiness to Change (Eigenvalue=2.1), and Setting and Achieving Diabetes Goals (Eigenvalue=1.9). (Ref: 3) It should be noted that principal components analysis tends to underestimate the number of factors as compared to principal axis factor analysis. Secondly, orthogonal rotations such as varimax are best followed up by non-orthogonal rotations to determine if factors are correlated. Thus, the reported results may not provide an accurate picture of the factor structure of the instrument. Additionally, the methods for determination of number of factors are not clearly articulated. Though an “iterative process” (Ref 3, p 740) was used to examine solutions with competing numbers of factors, the criteria used to judge the “3-factor solution to be the best” (Ref 3, p 741) are not described. Given that the original scale utilized 8 subscales while only 3 factors were extracted, the information regarding number-of-factor-determination would be helpful.

Normative Information Availability:

No information found.

Reliability Evidence

Test-retest:

Over a six-week time period, test-retest r=0.79 for the pilot version of the DES. (Ref: 3).

Inter-rater:

No information found. (N/A: self report instrument).

Internal Consistency:

Cronbach’s alpha for the 8 subscales on the pilot version ranged from 0.57 (emotional coping) to 0.85 (obtaining support). (Ref: 1) Subscale intercorrelations on the pilot version DES ranged from 0.21 to 0.71 in the developmental study and 0.45 to 0.80 in a study of males enrolled in a diabetes education program. (Ref: 2) The study of male patients also produced an overall reliability of alpha=0.96, while subscale alphas ranged from 0.56 to 0.90. (Ref: 2)

The revised version of the DES was found to have Cronbach’s alpha=0.96. Coefficient alpha for the three subscales ranged from 0.81 to 0.93. Correlations among the subscales ranged from 0.64 to 0.75. (Ref: 3)

Alternate Forms:

No information found.

Validity Evidence

Construct/ Convergent/ Discriminant:

The pilot version DES correlated at 0.45 with the Attitudes Toward Diabetes scale. All subscales correlated significantly and ranged from 0.29 to 0.47, except for the Readiness to Change subscale. (Ref: 2)

The DES subscales were correlated with several subscales of the Diabetes Care Profile (DCP). The DES correlated with the Positive Attitude scale at 0.32 to 0.59, the Negative Attitude scale at 0.38 to 0.59, and the Diabetes Understanding scale at 0.39 to 0.43. The DES correlated with level of education at 0.10 to 0.17. (Ref: 3)

Criterion-related/ Concurrent/ Predictive:

No information found.

Content:

Items are based on extensive research in the area of patient empowerment, thus content validity is supported. (Ref: 3) Content validity for the DES-SF was supported by the positive change in both the DES-SF scores and HbA1c levels following the completion of a 6-week education plan.

Responsiveness Evidence:

No information found.

Scale Application in VA Populations:

Yes. (Ref: 2)

Scale Application in non-VA Populations:

Yes. (Ref: 1,3)

Comments


The scales show reasonable reliability in the revised version and some validity in terms of correlations with other similar measures and some evidence of sensitivity to treatment. However, correlations with more objective measures, such as glycoslated hemoglobin would provide a stronger basis for use. In addition, test-retest reliabilities for the revised scale and subscales, including the short form, are needed.